Organization
University of Pretoria
1 clinical trial
4 abstracts
Abstract
Immune-phenotyping of peripheral blood mononuclear cells from patients with early triple-negative breast cancer: Identification of a systemic immunosuppressive CD3+ CD4+ CD39+ Treg subset.Org: University of Pretoria, Medical Oncology Centre of Rosebank, The Medical Oncology Centre of Rosebank,
Abstract
Demographics, pathologic characteristics, and pattern of recurrence of vulvar cancer at an academic hospital in South Africa: A 10-year retrospective review.Org: University of Pretoria, Pretoria, South Africa Health Product Regulatory Authority, Durban, South Africa,
Clinical trial
Prophylactic Vaccines as Therapy: Prevention of Recurrence of Extensive Genital WartsStatus: Active (not recruiting), Estimated PCD: 2025-05-31
Abstract
Transforming growth factor-b1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in advanced basal cell carcinoma.Org: University of Pretoria, Steve Biko Academic Hospital, The Medical Oncology Centre of Rosebank,
Abstract
A PROSPECTIVE STUDY OF EARLY RHEUMATOID ARTHRITIS IN SOUTH AFRICA: RESPONSE TO TRADITIONAL DMARDS IN AN IMPOVERISHED SETTINGOrg: Department of Medicine, Icahn School of Medicine at Mount Sinai, University of the Witwatersrand, Johannesburg, South Africa, Department of Immunology and Oncology, Clínica Universidad de Navarra, University of Pretoria, Epidemiology Data Centre,